{
  "abstract": "This article has been retracted.",
  "authors": [
    {
      "affiliations": [
        "Department of Neurology, Peking University People’s Hospital, Beijing, China"
      ],
      "name": "Zhaoxu Zhang"
    },
    {
      "affiliations": [
        "Department of Pain Rehabilitation, Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China",
        "Chinese Academy of Sciences, Hangzhou, China"
      ],
      "name": "Shuang Mei Zhang"
    },
    {
      "affiliations": [
        "Shandong Provincial Qianfoshan Hospital, Jinan, China"
      ],
      "name": "Anrong Wang"
    },
    {
      "affiliations": [
        "Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China"
      ],
      "name": "Xiaodong Song"
    },
    {
      "affiliations": [
        "Department of Pain Rehabilitation, Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China",
        "Chinese Academy of Sciences, Beijing, China"
      ],
      "name": "Pingbo Xu"
    }
  ],
  "title": "Exploring the therapeutic potential of IL-17A inhibition in myasthenia gravis: a retrospective study on secukinumab",
  "uid": "a24afabb-8d08-593d-aa16-ba6d190c3914"
}